Peptides of Laennec® preparation that contribute to the elimination of endotheliopathy
Objective: identification of peptides in the composition of Laennec®, which can inhibit the development of endotheliopathy (endothelial dysfunction).Material and methods. Hybrid mass spectrometry followed by data analysis based on topological recognition theory was performed. The analysis of the pep...
Saved in:
Main Authors: | I. Yu. Torshin (Author), О. А. Gromova (Author), V. G. Zgoda (Author), А. G. Chuchalin (Author), V. А. Maksimov (Author), О. V. Tikhonova (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peptides contained in the composition of Laennec that contribute to the treatment of hyperferritinemia and iron overload disorders
by: O. A. Gromova, et al.
Published: (2021) -
Analysis of the light peptide fraction of Laennec by proteomic methods
by: I. Yu. Torshin, et al.
Published: (2016) -
Nephroprotective peptides of Laennec® in the context of pharmacotherapy for nephro-hepato-metabolic disorders
by: O. A. Gromova, et al.
Published: (2024) -
Correction by Laennec of chronic iron overload liver, kidneys and brain
by: O. A. Nazarenko, et al.
Published: (2017) -
An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis
by: M. Imawari, et al.
Published: (2023)